VCIM
ELDN icon

Velan Capital Investment Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Velan Capital Investment Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-346,973
Closed -$899K – 49
2025
Q3 		$899K Buy
346,973
+8,000
+2% +$23.4K 0.84% 23
2025
Q2 		$919K Buy
338,973
+15,000
+5% +$45K 0.91% 24
2025
Q1 		$1.1M Hold
323,973
– – 1.13% 18
2024
Q4 		$1.33M Buy
+323,973
New +$1.28M 1.15% 15

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Velan Capital Investment Management's ELDN Position: Q4 2025 in Review

Velan Capital Investment Management sold out of Eledon Pharmaceuticals (ELDN) in Q4 2025, closing a stake of 346,973 shares — an estimated $899K sold.

Velan Capital Investment Management first reported a position in ELDN in Q4 2024 and held it in 4 quarters. The position peaked at $1.33M in Q4 2024. 95 funds tracked by Wall St. Rank hold ELDN as of Q4 2025.

  • Velan Capital Investment Management reported no remaining Eledon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 346,973 Eledon Pharmaceuticals shares in Q4 2025, an estimated $899K.
  • Velan Capital Investment Management first reported a position in Eledon Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Velan Capital Investment Management's Eledon Pharmaceuticals position peaked at $1.33M in Q4 2024.
  • 95 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2025.

Based on Velan Capital Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.